405 related articles for article (PubMed ID: 17522436)
1. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
[TBL] [Abstract][Full Text] [Related]
2. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
3. Human lymphoblastoid cell line producing protective monoclonal IgG1, kappa anti-tetanus toxin.
Tiebout RF; Stricker EA; Hagenaars R; Zeijlemaker WP
Eur J Immunol; 1984 May; 14(5):399-404. PubMed ID: 6327321
[TBL] [Abstract][Full Text] [Related]
4. Antibody production of a human EBV-transformed B cell line and its heterohybridoma and trioma cell line descendants in different culture systems.
Gustafsson B; Hinkula J
Hum Antibodies Hybridomas; 1994; 5(3-4):98-104. PubMed ID: 7756584
[TBL] [Abstract][Full Text] [Related]
5. Bacterial expression of a human recombinant monoclonal antibody fab fragment against hepatitis B surface antigen.
Maeda F; Nagatsuka Y; Ihara S; Aotsuka S; Ono Y; Inoko H; Takekoshi M
J Med Virol; 1999 Aug; 58(4):338-45. PubMed ID: 10421399
[TBL] [Abstract][Full Text] [Related]
6. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line.
Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R
Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878
[TBL] [Abstract][Full Text] [Related]
7. [Attempts to improve hybridoma technology for the production of human monoclonal antibodies].
Tokunaga T; Chiba J; Ohnishi K
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2198-204. PubMed ID: 3038035
[TBL] [Abstract][Full Text] [Related]
8. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
[TBL] [Abstract][Full Text] [Related]
9. A human monoclonal antimelanoma single-chain Fv antibody derived from tumor-infiltrating lymphocytes.
Zhang H; Lake DF; Barbuto JA; Bernstein RM; Grimes WJ; Hersh EM
Cancer Res; 1995 Aug; 55(16):3584-91. PubMed ID: 7627967
[TBL] [Abstract][Full Text] [Related]
10. Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV)-transformation.
Steinitz M; Koskimies S; Klein G; Mäkelä O
J Clin Lab Immunol; 1979 Apr; 2(1):1-7. PubMed ID: 95800
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the N-glycans of human monoclonal immunoglobulins M produced by hybridoma and parental cells.
Fukuta K; Abe R; Yokomatsu T; Kono N; Nagatomi Y; Asanagi M; Shimazaki Y; Makino T
Arch Biochem Biophys; 2000 Jun; 378(1):142-50. PubMed ID: 10871054
[TBL] [Abstract][Full Text] [Related]
12. A human hybrid hybridoma.
Tiebout RF; van Boxtel-Oosterhof F; Stricker EA; Zeijlemaker WP
J Immunol; 1987 Nov; 139(10):3402-5. PubMed ID: 3119707
[TBL] [Abstract][Full Text] [Related]
13. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines.
Hilfenhaus J; Kanzy EJ; Köhler R; Willems WR
Behring Inst Mitt; 1986 Jun; (80):31-41. PubMed ID: 3019293
[TBL] [Abstract][Full Text] [Related]
14. Induction of antibody-producing cell lines by Epstein-Barr virus.
Viallat JR; Kourilsky FM
Pathol Biol (Paris); 1982 Apr; 30(4):232-42. PubMed ID: 6283460
[TBL] [Abstract][Full Text] [Related]
15. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
Garzelli C; Puglisi C; Falcone G
Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
[TBL] [Abstract][Full Text] [Related]
16. Efficient expression of recombinant human monoclonal antibodies in Drosophila S2 cells.
Johansson DX; Drakenberg K; Hopmann KH; Schmidt A; Yari F; Hinkula J; Persson MA
J Immunol Methods; 2007 Jan; 318(1-2):37-46. PubMed ID: 17137589
[TBL] [Abstract][Full Text] [Related]
17. A human monoclonal antibody to cytomegalovirus (CMV).
Emanuel D; Gold J; Colacino J; Lopez C; Hammerling U
J Immunol; 1984 Oct; 133(4):2202-5. PubMed ID: 6088634
[TBL] [Abstract][Full Text] [Related]
18. A strategy for the production of human monoclonal antibodies reactive with lung tumor cell lines.
Cole SP; Campling BG; Louwman IH; Kozbor D; Roder JC
Cancer Res; 1984 Jul; 44(7):2750-3. PubMed ID: 6327024
[TBL] [Abstract][Full Text] [Related]
19. Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells.
Rosén A; Persson K; Klein G
J Immunol; 1983 Jun; 130(6):2899-902. PubMed ID: 6189902
[TBL] [Abstract][Full Text] [Related]
20. [Monoclonal antibodies produced by human-human hybridomas].
Chida J
Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
